HFS
VRPX

Hantz Financial Services’s Virpax Pharmaceuticals, Inc. Common Stock VRPX Stock Holding History

Hantz Financial Services’s Portfolio VRPX Stock Details VRPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Hold
0
– – – 2019
2024
Q4 		– Hold
0
– – – 1240
2024
Q3 		– Hold
0
– – – 1216
2024
Q2 		– Hold
0
– – – 1321
2024
Q1 		– Hold
0
– – – 1321
2023
Q4 		– Hold
0
– – – 1250
2023
Q3 		– Hold
0
– – – 1206
2023
Q2 		– Hold
0
– – – 1202
2023
Q1 		– Hold
0
– – – 1226
2022
Q4 		– Hold
0
– – – 1180
2022
Q3 		– Hold
0
– – – 1159
2022
Q2 		– Hold
0
– – – 1135
2022
Q1 		– Hold
0
– – – 1137

Other funds holding VRPX

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VWM
Vermillion Wealth Management Rosemount, Minnesota $427M AUM 12.63% 1-Year Est. Return